Concepedia

Publication | Open Access

<p>Baseline Lymphopenia: A Predictor Of Poor Outcomes In HER2 positive Metastatic Breast Cancer Treated With Trastuzumab</p>

DOIFull Paper Access

15

Citations

15

References

2019

Year

Yi‐Qun Che, Yue Zhang, Di Wang, Hui‐Ying Liu, Di Shen, Yang Luo
Drug Design Development and Therapy

Abstract

Our data indicate that baseline ALC value of ≤1 G/L is a predictor of poor outcomes, but not of response, in patients with MBC treated with trastuzumab.

References

YearCitations

Page 1